In todays fast-paced world, chronic inflammation has emerged as a silent health epidemic, contributing to a myriad of ailments, from minor aches to severe diseases like arthritis, heart disease, and ...
MP-1032 is under clinical development by MetrioPharm and currently in Phase I for Inflammatory Bowel Disease. According to GlobalData, Phase I drugs for Inflammatory Bowel Disease have a 73% phase ...
Vyvdura receives Japanese regulatory approval for adults with chronic inflammatory demyelinating polyneuropathy: Rotterdam, the Netherlands Monday, December 30, 2024, 1 ...